-
1دورية أكاديمية
المؤلفون: Ken Tanaka, Hiroaki Miyoshi, Yusuke Yamashita, Ryuta Iwamoto, Yuma Yokoya, Yuichi Tochino, Fumiko Arakawa, Shinobu Tamura, Shin-Ichi Murata, Takashi Sonoki, Koichi Ohshima
المصدر: Hematology Reports, Vol 15, Iss 4, Pp 662-669 (2023)
مصطلحات موضوعية: classic hodgkin lymphoma, lymphocyte rich classic hodgkin lymphoma, angioimmunoblastic T-cell lymphoma, secondary non-hodgkin lymphoma, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Akira Satou, Ayako Sakakibara, Harumi Kato, Katsuya Furukawa, Kazuhito Yamamoto, Kazuyuki Shimada, Kei Kohno, Mamiko Sakata-Yanagimoto, Seiichi Kato, Shigeo Nakamura, Yuichi Ishikawa, Yuka Suzuki
المصدر: Journal of Clinical and Experimental Hematopathology. 2021, 61(2):97
-
3
المؤلفون: Harumi Kato, Shigeo Nakamura, Kazuhito Yamamoto, Mamiko Sakata-Yanagimoto, Seiichi Kato, Yuichi Ishikawa, Katsuya Furukawa, Kei Kohno, Ayako Sakakibara, Kazuyuki Shimada, Akira Satou, Yuka Suzuki
المصدر: Journal of Clinical and Experimental Hematopathology : JCEH
مصطلحات موضوعية: Male, Pathology, medicine.medical_specialty, CD30, T-Lymphocytes, Follicular lymphoma, Case Report, diagnostic pitfall, CD15, Biology, medicine.disease_cause, Lymphoma, T-Cell, programmed cell death protein 1 (PD1), immune system diseases, RHOA mutation, hemic and lymphatic diseases, medicine, T-cell lymphoma, Humans, Lymphoma, Follicular, Follicular T-cell lymphoma, Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor, General Medicine, Gene rearrangement, Middle Aged, medicine.disease, Epstein–Barr virus, Hodgkin Disease, lymphocyte-rich classic Hodgkin lymphoma, Lymphoma, PAX5
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809e9bb46502d4d4287b445070da7e41Test
https://tsukuba.repo.nii.ac.jp/records/2003789Test -
4دورية أكاديمية
المؤلفون: Akira Satou, Ayako Sakakibara, Harumi Kato, Katsuya Furukawa, Kazuhito Yamamoto, Kazuyuki Shimada, Kei Kohno, Mamiko Sakata-Yanagimoto, Seiichi Kato, Shigeo Nakamura, Yuichi Ishikawa, Yuka Suzuki
المصدر: Journal of Clinical and Experimental Hematopathology. :20052
-
5تقرير
المصدر: A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03907488Test
-
6تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase 2 Front-Line PET/CT-2 Response-Adapted Brentuximab Vedotin and Nivolumab Incorporated and Radiation-Free Management of Early Stage Classical Hodgkin Lymphoma (cHL)
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03712202Test